Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Molecular Immunology|September 20, 2021
The glycosylation status of MHC class I molecules impacts their interactions with TAPBPRF Tudor Ilca, Louise H BoyleThe Bone & Joint Journal|May 5, 2016
Revision surgery for the stiff total knee arthroplastyJ R Donaldson, F Tudor, J GollishCell Reports|November 7, 2019
Distinct Polymorphisms in HLA Class I Molecules Govern Their Susceptibility to Peptide Editing by TAPBPRF Tudor Ilca, Linnea Z Drexhage, Gemma Brewin, et al.Proceedings of the National Academy of Sciences of the United States of America|September 15, 2018
Utilizing TAPBPR to promote exogenous peptide loading onto cell surface MHC I moleculesF Tudor Ilca, Andreas Neerincx, Mark R Wills, et al.Revista De Medicina Interna, Neurologe, Psihiatrie, Neurochirurgie, Dermato-Venerologie. Medicina Interna|January 1, 1989
[Acute lymphoblastic Ph1-positive leukemia with a hybrid phenotype. The significance of the Ph1 anomaly and the hybrid phenotype]S Nicoară, D Stefănescu, S Roman, et al.Elife|November 29, 2018
TAPBPR mediates peptide dissociation from MHC class I using a leucine leverF Tudor Ilca, Andreas Neerincx, Clemens Hermann, et al.Biochimica Et Biophysica Acta|May 21, 1975
Xeonon accumulation in the red blood cell. A process latered by suppressors of the membrane active transport functionC T Dragomir, D T Stefãnescu, I Georgescu, et al.Antiviral Research|August 10, 2021
A tetrameric ACE2 protein broadly neutralizes SARS-CoV-2 spike variants of concern with elevated potencyAdam Leach, F Tudor Ilca, Zulaikha Akbar, et al.Blood Cancer Journal|February 29, 2024
Dual T-cell constant β chain (TRBC)1 and TRBC2 staining for the identification of T-cell neoplasms by flow cytometryPedro Horna, Matthew J Weybright, Mathieu Ferrari, et al.Journal of Virology|July 21, 2021
Characterization of a Novel ACE2-Based Therapeutic with Enhanced Rather than Reduced Activity against SARS-CoV-2 VariantsMathieu Ferrari, Leila Mekkaoui, F Tudor Ilca, et al.Pageof 1